Catalog Number 70700 |
Device Problem
Patient-Device Incompatibility (2682)
|
Patient Problems
Bacterial Infection (1735); Fever (1858); Staphylococcus Aureus (2058)
|
Event Date 02/22/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
Investigation: per the customer, during the rbcx, the patient's mother had stated that the patient wasn't her usual self and was exhausted.She also stated that the patient had flu like symptoms a few days before.Per the customer, the patient's temperature increased from 36.7 degree celsius to 38.2 degree celsius during the procedure.Internal investigation is in process a the hospital and the mobile apheresis unit.The customer stated that the patient is having the vortex port removed.Per the customer, there were two incidents of line contamination at this hospital associated with this lot.The other incident has been reported on mdr # 1722028-2016-00147.There are no other similar reports associated with this lot number.Investigation is in process.A follow-up report will be provided.
|
|
Event Description
|
The customer reported that the hospital to which they provide apheresis units had a patient with a line infection (right chest vertex port) by a bacteria, staph aureus.The patient underwent a red blood cell exchange (rbcx) procedure with 996mls of packed rbcs.The units were associated with lot # 08y15237.The evening after the rbcx procedure, the patient presented to the er with a fever.Per physician's order, the patient was given 5 days of antibiotics.The patient is reported in stable condition currently.The customer declined to provide the patient's identifier and weight.The disposable kit is not available for return, because it was discarded by the customer.
|
|
Manufacturer Narrative
|
This report is being filed to provide additional information.Investigation is in progress.A follow-up report will be provided.
|
|
Manufacturer Narrative
|
This report is being filed to provide corrected incident date and additional information.Investigation: a review of the device history record for this unit showed no irregularities during manufacturing that were relevant to this issue.Investigation is in progress.A follow-up report will be provided.
|
|
Manufacturer Narrative
|
The customer stated that the bacterial strain is staph aureus.Based on literature review, staph aurerus is a bacteria that is frequently found on the skin.S.Aureus is observed in severe transfusion reactions, which are thought to be the result of inadequate skin disinfection or transient bacteremia of the donor at the time of donation.The devices terumo bct manufactures to collect, separate, and store blood products are terminally sterilized to a sterility assurance level(sal) of= 10-6.Additionally, a sterility assurance system has been designed and employed to ensure this sal will be achieved for every lot of product manufactured.The sterility assurance system employed at terumo bct ensures the disposable device is not the source of contamination root cause: based on the investigation results, the disposable set is not the source of the bacterial contamination.A root cause could not be determined.Sources of bacterial contamination include but are not limited to: patient connection to the disposable set (venipuncture), post-processing laboratory practices and handling, and/or storage procedures.Literature review: http://www.Ncbi.Nlm.Nih.Gov/pmc/articles/pmc1153802.
|
|
Search Alerts/Recalls
|